It is the stuff of parental nightmares. Between July and October 70 children in Gambia died of kidney failure. In December 18 perished in Uzbekistan from renal problems and acute respiratory disease. In both cases Indian-made cough syrups may have been at fault, according to allegations by a Gambian parliamentary committee and the Uzbek authorities.
Listen to this story. Enjoy more audio and podcasts on iOS or Android.
Your browser does not support the <audio> element.
Listen to this story
Save time by listening to our audio articles as you multitask
OK
The manufacturer in the Uzbek case, Marion Biotech, has been suspended from Pharmexcil, an Indian
→ Continue reading at The Economist
